Dafil (@dafil) header
Dafil (@dafil) profile picture

Opinions are my own! 🇨🇦🇧🇩

Toronto, Ontario
Joined April 2009
Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)Photo by Dafil (@dafil)
Pinned Tweet
We have released SNV/Indel/SV pathogenicity Analysis Software Horizon. With Horizon, you can get germline and somatic variant insight for free. You can start small clinical genomics project yourself right away in our cloud, without a high-spec server. variant.genomearc.com/
3
1
2
326
💥 When "uncertain" becomes "causal" We called PPP1R9A a VUS — accurate for the evidence then. Now: CRISPR neurons grew larger dendrites but fired poorly. More structure, less function. That's what moves a variant. genomearc.com/blog-show/MzY6… #RareDisease #Genomics
1
4
98
CADD, REVEL and AlphaMissense agreeing on a variant is not three lines of evidence. It's one line of evidence, said three times, by three models trained on overlapping data. PP3 doesn't stack. #genomics #longread #ACMG
1
3
96
From a VUS → neuronal dysfunction → therapeutic design. 🧬🧠 At CATG, MBRU, Dubai Health, we built an isogenic CRISPR-iPSC model of human cortical neurons with heterozygous PPP1R9A (Neurabin I) loss—turning a long-standing VUS into a functional mechanism.
1
1
2
203
Mutant neurons showed abnormal spinogenesis, dendritic complexity, and reduced action-potential firing. Long-read RNA-seq + proteomics revealed profound disruption of ion channels, synaptic transmission, glutamatergic signaling, and deep-layer cortical neuron programs.
1
1
34
💥 Then came the exciting part: we designed an allele-specific ASO and full-length Neurabin replacement strategy, restoring molecular stability and reversing dysregulated synaptic programs. From variant → mechanism → therapeutic strategy. 🚀
1
23
1
3
21
Search Somatic variant AMP tiers, with global access for 27 tumor type : variant.genomearc.com/
1
1
3
123
It is fascinating to see how Anthropic beating @elonmusk in AI race, BYD beating @Tesla , Honda, Blue Origin started to compete @SpaceX and Synchron is already creating more impact than @neuralink Talent all around the world must be celebrated, not just one person.
2
63
Dafil retweeted
A VUS with no second case stays a VUS. 🧬Search your variant free against Horizon's rare disease databases to find matching patients elsewhere. We have millions of currated variants to share. variant.genomearc.com/ #rarediseases #VUS #genome #diagnosis #genetics
1
3
328
The studio will never forget
8,014
74,383
5,559
634,451
79,578,172
Dafil retweeted
Struggling with tricky variants in rare neurodevelopmental disorders? We unpacked 3 real cases in Horizon Series: 🧬 TCF4 – broader phenotypes 🧬KCNH1 - G6PD focal epilepsy 🧬KMT2D – Kabuki syndrome Long-read genomics delivering answers. #raredisease #Genomics #VUS #Gene
1
1
3
90
RIP THE SCRIPT @Nike #Ad
11,069
78,732
10,323
663,484
50,631,986
WORLD CUP VIDEO OUT NOW!!!!⚽️
6,110
36,155
6,572
459,932
84,348,960
Global Access, for everyone, predicting variant effect for rare disease (ACMG) and cancer (AMP). Type you germline or somatic variant for interpretation: variant.genomearc.com/ #raredisease #cancer #tumor #VUS #longread #genomics #genome #ACMG #AMP #somatic
1
2
76
NF1 deletion increases tumor risk. Horizon variant server returns multi-layer insights for geneticists: 🧬pathogenicity, 💊clinical trial drug insight, 🏥 three additional NF1 deletion samples Search your CNV/SV: variant.genomearc.com/ #NF1 #rarediseases #cancer #tumor #CNV
1
4
94
TF4 Gene variants and neurodevelopmental disorders. Part of GenomeArc's clinical genetics case series. 👉 Registration link in the comments. 📍 Watch (May 25, 2026) the case series on TCF4-related disorders:lnkd.in/gWfv97RB #raredisease #TCF4
1
2
50
Amazing! Since its launch one month ago, 50 genomic institutes are using Horizon ACMG/AMP variant classification server with free global access. Search your rare disease or tumor variant: variant.genomearc.com/ #raredisease #cancer #tumor #ACMG #AMP #variant #VUS
1
2
76